FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

387525002: Hydrochlorothiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461703016 Hydrochlorothiazide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481615017 Hydrochlorothiazide en Synonym Active Entire term case insensitive SNOMED CT core module
1492148015 HCTZ en Synonym Active Entire term case sensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydrochlorothiazide Is a Thiazide diuretic true Inferred relationship Existential restriction modifier
Hydrochlorothiazide Is a Benzothiadiazine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely bisoprolol fumarate 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely bisoprolol fumarate 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely enalapril maleate 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely enalapril maleate 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely enalapril maleate 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely enalapril maleate 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely eprosartan (as eprosartan mesilate) 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely fosinopril sodium 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely fosinopril sodium 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely fosinopril sodium 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely fosinopril sodium 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely captopril 25 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 15 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 30 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 30 milligram and methyldopa 500 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet Has basis of strength substance False Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet Has precise active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 80 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely benazepril hydrochloride 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely benazepril hydrochloride 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely candesartan cilexetil 32 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely candesartan cilexetil 32 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 7.5 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 25 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 25 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril (as quinapril hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing hydrochlorothiazide and nebivolol (medicinal product) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing hydrochlorothiazide and nebivolol in oral dose form (medicinal product form) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing only hydrochlorothiazide and nebivolol in oral dose form (medicinal product form) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing only hydrochlorothiazide and nebivolol (medicinal product) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 1
Product containing only hydrochlorothiazide and levamlodipine (medicinal product) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing hydrochlorothiazide and levamlodipine (medicinal product) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing hydrochlorothiazide and levamlodipine in oral dose form (medicinal product form) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing only hydrochlorothiazide and levamlodipine in oral dose form (medicinal product form) Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet Has active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Has active ingredient False Hydrochlorothiazide Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets (Tillomed Laboratories Ltd) Has specific active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets (Tillomed Laboratories Ltd) 28 tablet Has specific active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets (Tillomed Laboratories Ltd) 28 tablet Has specific active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier
Co-amilozide 2.5mg/25mg tablets (Tillomed Laboratories Ltd) Has specific active ingredient True Hydrochlorothiazide Inferred relationship Existential restriction modifier

Start Previous Page 7 of 26 Next End

This concept is not in any reference sets

Back to Start